Suzhou Ribo Life Science Co., Ltd. (HKG:6938)

Suzhou Ribo Life Science Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	2,242	406.75	183.62	212.35	238.12	105.11
Short-Term Investments	-	1.59	1.54	2.92	-	-
Cash & Short-Term Investments	2,274	408.34	185.16	215.27	238.12	105.11
Cash Growth	314.04%	120.53%	-13.98%	-9.60%	126.55%	-51.45%
Accounts Receivable	60.41	5.46	3.47	0.01	-	-
Other Receivables	-	30.52	31.28	38.58	0.92	1.46
Receivables	60.41	35.98	34.75	38.59	0.92	1.46
Inventory	61.63	54.93	42.72	45.6	19.87	10.17
Other Current Assets	114.94	17.8	6.66	10.02	20.87	8.24
Total Current Assets	2,511	517.05	269.29	309.48	279.79	124.98
Property, Plant & Equipment	230.54	245.04	276.1	296.79	44.83	29.36
Other Intangible Assets	69.05	76.83	92.47	108.42	88.49	99.86
Other Long-Term Assets	7.98	0.89	12.99	1.57	18.96	14.63
Total Assets	2,819	839.81	650.86	716.25	432.07	268.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Accounts Payable	23.2	11.63	24.23	23.27	5.61	6.71
Accrued Expenses	27.31	37.49	26.13	26.51	12.33	7.09
Short-Term Debt	-	-	12.43	12.1	76.08	-
Current Portion of Long-Term Debt	218.2	373.03	214.18	205.18	-	-
Current Portion of Leases	9.01	12.06	7.63	8.09	-	-
Current Income Taxes Payable	1.43	1.44	1.24	-	0.62	0.38
Current Unearned Revenue	117.42	78.99	81.02	14.49	12.28	10.27
Other Current Liabilities	78.62	86.78	47.46	38.21	2.93	2.09
Total Current Liabilities	475.18	601.41	414.31	327.85	109.85	26.53
Long-Term Debt	304.98	149.38	172.28	163.71	-	-
Long-Term Leases	10.58	15.6	22.36	25.66	-	-
Long-Term Unearned Revenue	171.25	32.88	89.7	24.15	0.88	1.64
Other Long-Term Liabilities	14.23	13.76	63.28	59.16	9.75	-
Total Liabilities	976.22	813.04	761.93	600.53	120.49	28.17

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Common Stock	170.56	134.2	129.61	128.39	29.81	27.04
Additional Paid-In Capital	-	1,557	1,283	1,046	683.49	480.52
Retained Earnings	-	-1,800	-1,522	-1,252	-400.37	-266.01
Comprehensive Income & Other	1,559	14.41	-0.88	182.34	-	-
Total Common Equity	1,730	-93.94	-110.36	105.1	312.93	241.55
Minority Interest	112.99	120.71	-0.71	10.62	-1.35	-0.9
Shareholders' Equity	1,843	26.77	-111.07	115.72	311.58	240.65
Total Liabilities & Equity	2,819	839.81	650.86	716.25	432.07	268.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Total Debt	542.76	550.07	428.88	414.74	76.08	-
Net Cash (Debt)	1,731	-141.73	-243.72	-199.47	162.04	105.11
Net Cash Growth	3606.35%	-	-	-	54.16%	-51.45%
Net Cash Per Share	11.48	-1.07	-1.89	-1.55	5.44	3.89
Filing Date Shares Outstanding	170.56	134.2	134.2	128.39	29.81	27.04
Total Common Shares Outstanding	170.56	134.2	129.61	128.39	29.81	27.04
Working Capital	2,036	-84.36	-145.01	-18.38	169.94	98.45
Book Value Per Share	10.14	-0.70	-0.85	0.82	10.50	8.93
Tangible Book Value	1,660	-170.77	-202.83	-3.32	224.45	141.69
Tangible Book Value Per Share	9.74	-1.27	-1.56	-0.03	7.53	5.24
Buildings	-	121.74	128.17	128.17	-	-
Machinery	-	173.51	169.47	161.97	71.13	48.46
Leasehold Improvements	-	4.28	4.28	4.28	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error